The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Spanish active pharmaceutical ingredient (API) maker Interquim, S.A. for several good manufacturing practices ...
The FDA said in a warning letter that an Indian API maker had not ensured the water it gets from a nearby river is sanitary before using it to make its products. () The FDA has suggested an Indian API ...
The FDA found that a Canadian API maker was not testing the products it shipped to the U.S. (FDA) An FDA inspector didn’t have to spend long to discover that a Canadian API maker was failing to meet ...
The US Food and Drug Administration (FDA) on Monday released a warning letter sent to active pharmaceutical ingredient (API) maker Qinhuangdao Zizhu Pharmaceutical for data integrity issues uncovered ...
An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...
Mumbai, Oct 12 () Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday. Mumbai, Oct 12 ( ...
In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker.
Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday announced that it has entered into an agreement to acquire 100 per cent stake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results